Synthesis of novel umbelliferone derivatives.
Anti proliferative activity in human breast (MCF-7) and human prostate (22Rv1) cancer cell lines.
50-Fold improvement over the clinical antiandrogen bicalutamide.
Molecular modeling studies provide theoretical explanation for our findings.